Recursion is a pharmatech company and the first to automate drug discovery, generating its own data before combining the analytical power of AI with the creativity and expertise of our world-class scientists. This allows Recursion to shorten the pre-clinical drug discovery stage by at least three-quarters and, in turn, substantially accelerate the delivery of new treatments.